Revolution Medicines

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Form 4 Revolution Medicines Inc For: 1 October By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 01.10.2026

• Revolution Medicines’ CDO Sandler sells $1.2m in stock By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 01.10.2026

• Form 4 Revolution Medicines Inc For: 29 September By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 30.09.2026

• Revolution Medicines SVP Cislini sells $158,599 in shares By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 29.09.2026

• Revolution Medicines SVP Cislini sells $158,599 in shares (öffnet in neuem Tab)

  Investing.com · 29.09.2026

• Revolution Medicines SVP Jeff Cislini Sells 765 Shares Under 10b5-1 Trading Plan (öffnet in neuem Tab)

  kalkinemedia.com · 29.09.2026

• 6,000 shares from exercised options are listed for an officer’s proposed sale at Revolution Medicines (RVMD). (öffnet in neuem Tab)

  Stock Titan · 29.09.2026

• Does Rasonque Launch Change The Bull Case For Revolution Medicines Stock? (öffnet in neuem Tab)

  Simply Wall Street · 29.09.2026

• LifeSci Capital Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $315 (öffnet in neuem Tab)

  Moomoo · 29.09.2026

• Form 4 Revolution Medicines Inc For: 28 September By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 28.09.2026

• Revolution Medicines officer Mancini sells $743k in stock By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 28.09.2026

• Revolution Medicines officer Mancini sells $743k in stock (öffnet in neuem Tab)

  Investing.com India · 28.09.2026

• Brookline initiates Revolution Medicines stock with buy rating By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 28.09.2026

• Form 144 REVOLUTION MEDICINES INC For: 27 September By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 27.09.2026

• Stock options are the source of 9,363 shares a Revolution Medicines (RVMD) officer proposes to sell. (öffnet in neuem Tab)

  Stock Titan · 25.09.2026

• Revolution Medicines (RVMD) Wins FDA Breakthrough Status On Questions Of Whether The Stock Is Fully Valued (öffnet in neuem Tab)

  Simply Wall Street · 25.09.2026

• Revolution Medicines Receives FDA Breakthrough Designation, Royalty Pharma Offers a Diversified Investment Path (öffnet in neuem Tab)

  NAI500 · 25.09.2026

• Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? (öffnet in neuem Tab)

  The Motley Fool · 25.09.2026

• Revolution Medicines director Elizabeth Anderson sells $1.96m in stock By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 24.09.2026

• Form 4 Revolution Medicines Inc For: 24 September By Investing.com (öffnet in neuem Tab)

  Investing.com India · 24.09.2026

• Revolution Medicines (RVMD) director exercises options for 5,070 shares and sells 10,143 shares. (öffnet in neuem Tab)

  Stock Titan · 24.09.2026

• Revolution Medicines Gains as New Buy Rating Adds to Recent Regulatory Momentum (öffnet in neuem Tab)

  Quiver Quantitative · 24.09.2026

• Goldman Sparks Surge In Revolution Medicines Shares (öffnet in neuem Tab)

  TipRanks · 24.09.2026

• After three earlier sales, an officer proposes selling 587 more Revolution Medicines (RVMD) shares. (öffnet in neuem Tab)

  Stock Titan · 24.09.2026

• How (RVMD) Movements Inform Risk Allocation Models (öffnet in neuem Tab)

  Stock Traders Daily · 23.09.2026

• Is Revolution Medicines (RVMD) Cheap After Its FDA Breakthrough Therapy Win? (öffnet in neuem Tab)

  Yahoo Finance · 23.09.2026

• Revolution Medicines (NASDAQ: RVMD) director plans stock sale from option exercise (öffnet in neuem Tab)

  Stock Titan · 22.09.2026

• Here's How Much $1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth Today (öffnet in neuem Tab)

  Benzinga · 22.09.2026

• Revolution Medicines (RVMD) Deepens RAS(ON) Bet With Breakthrough PDAC Combo – But Is Risk Repricing? (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026

• Revolution Medicines (RVMD) Wins FDA Breakthrough Status For RASONQUE (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026